|
C1ORF131 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.475530E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.536300E-02 |
| Normal-vs-Stage2 |
3.390200E-01 |
| Normal-vs-Stage3 |
1.268000E-02 |
| Normal-vs-Stage4 |
2.834400E-01 |
| Stage1-vs-Stage2 |
8.104200E-01 |
| Stage1-vs-Stage3 |
6.784100E-02 |
| Stage1-vs-Stage4 |
5.380000E-01 |
| Stage2-vs-Stage3 |
7.228000E-02 |
| Stage2-vs-Stage4 |
5.123400E-01 |
| Stage3-vs-Stage4 |
4.575200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.478900E-03 |
| Normal-vs-AfricanAmerican |
3.007700E-02 |
| Normal-vs-Asian |
3.631800E-01 |
| Caucasian-vs-AfricanAmerican |
7.121800E-01 |
| Caucasian-vs-Asian |
7.712200E-01 |
| AfricanAmerican-vs-Asian |
6.301000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.213890E-02 |
| Normal-vs-Female |
9.370900E-04 |
| Male-vs-Female |
6.756000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.145600E-01 |
| Normal-vs-Extreme_Weight |
6.151900E-02 |
| Normal-vs-Obese |
2.150400E-02 |
| Normal-vs-Extreme_Obese |
2.963800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.567200E-01 |
| Normal_Weight-vs-Obese |
8.295400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.891200E-01 |
| Extreme_Weight-vs-Obese |
5.159600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.113000E-01 |
| Obese-vs-Extreme_Obese |
9.764000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.394000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.94110000000847E-05 |
| Normal-vs-Age(61-80Yrs) |
8.022200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.789000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.592400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.661990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.354200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.909600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.440360E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.204000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.178100E-04 |
| Normal-VS-Type2 PRCC |
2.942400E-01 |
| Normal-VS-KIRP CIMP |
3.611400E-01 |
| Normal-VS-Unclassified PRCC |
7.020100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.890030E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.953800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.995000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.374600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.835600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.373000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.475200E-01 |
| Normal-vs-N1 |
9.217200E-03 |
| Normal-vs-N2 |
9.352800E-01 |
| N0-vs-N1 |
1.907890E-02 |
| N0-vs-N2 |
8.352200E-01 |
| N1-vs-N2 |
2.807400E-01 |
|
|
